Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.

CONCLUSIONS: Overall, both 1-month and 3-month formulations of PDP are safe and effective in the treatment of schizophrenia and schizoaffective disorder. They may be most effective in patients with prior failed treatment of oral antipsychotics or other LAIAs, in patients with a history of medication noncompliance, or in patients with an individual preference for less frequent dosing. PMID: 28626271 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28626271?dopt=Abstract

Source: Psychopharmacology Bulletin - June 20, 2017 Category: Psychiatry & Psychology Tags: Psychopharmacol Bull Source Type: research